↓ Skip to main content

A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance…

Overview of attention for article published in Trials, June 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)

Mentioned by

twitter
16 tweeters
facebook
2 Facebook pages

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
37 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial
Published in
Trials, June 2019
DOI 10.1186/s13063-019-3390-8
Pubmed ID
Authors

Larisa Duffy, Faye Bacon, Caroline S. Clarke, Yvonne Donkor, Nick Freemantle, Simon Gilbody, Rachael Hunter, Tony Kendrick, David Kessler, Michael King, Paul Lanham, Gemma Lewis, Dee Mangin, Louise Marston, Michael Moore, Irwin Nazareth, Nicola Wiles, Glyn Lewis

Twitter Demographics

The data shown below were collected from the profiles of 16 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 37 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 27%
Student > Bachelor 9 24%
Researcher 7 19%
Student > Ph. D. Student 2 5%
Student > Postgraduate 2 5%
Other 5 14%
Unknown 2 5%
Readers by discipline Count As %
Medicine and Dentistry 15 41%
Psychology 11 30%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Economics, Econometrics and Finance 2 5%
Nursing and Health Professions 1 3%
Other 2 5%
Unknown 4 11%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 December 2019.
All research outputs
#2,412,484
of 15,835,365 outputs
Outputs from Trials
#956
of 4,175 outputs
Outputs of similar age
#57,278
of 268,485 outputs
Outputs of similar age from Trials
#1
of 1 outputs
Altmetric has tracked 15,835,365 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,175 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.7. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 268,485 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them